Ikuti
Srinivas Ganta
Srinivas Ganta
Synta Pharmaceuticals
Email yang diverifikasi di syntapharma.com
Judul
Dikutip oleh
Dikutip oleh
Tahun
A review of stimuli-responsive nanocarriers for drug and gene delivery
S Ganta, H Devalapally, A Shahiwala, M Amiji
Journal of controlled release 126 (3), 187-204, 2008
24542008
Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells
S Ganta, M Amiji
Molecular pharmaceutics 6 (3), 928-939, 2009
5772009
Role of integrated cancer nanomedicine in overcoming drug resistance
AK Iyer, A Singh, S Ganta, MM Amiji
Advanced drug delivery reviews 65 (13-14), 1784-1802, 2013
3532013
Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields
M Chorny, I Fishbein, BB Yellen, IS Alferiev, M Bakay, S Ganta, R Adamo, ...
Proceedings of the National Academy of Sciences 107 (18), 8346-8351, 2010
2422010
Nanoemulsions in translational research—opportunities and challenges in targeted cancer therapy
S Ganta, M Talekar, A Singh, TP Coleman, MM Amiji
Aaps Pharmscitech 15, 694-708, 2014
2272014
Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation
S Ganta, H Devalapally, M Amiji
Journal of pharmaceutical sciences 99 (11), 4630-4641, 2010
1542010
Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery
S Ganta, JW Paxton, BC Baguley, S Garg
International Journal of Pharmaceutics 367 (1-2), 179-186, 2009
1432009
Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery
SC Abeylath, S Ganta, AK Iyer, M Amiji
Accounts of chemical research 44 (10), 1009-1017, 2011
1332011
A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers
S Ganta, D Deshpande, A Korde, M Amiji
Molecular membrane biology 27 (7), 260-273, 2010
1062010
Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice
CA Dehelean, S Feflea, D Gheorgheosu, S Ganta, AM Cimpean, ...
Journal of biomedical nanotechnology 9 (4), 577-589, 2013
902013
Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay
CA Dehelean, S Feflea, S Ganta, M Amiji
Journal of biomedical nanotechnology 7 (2), 317-324, 2011
872011
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion
S Ganta, JW Paxton, BC Baguley, S Garg
International journal of pharmaceutics 360 (1-2), 115-121, 2008
872008
Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer
S Ganta, A Singh, Y Rawal, J Cacaccio, NR Patel, P Kulkarni, CF Ferris, ...
Drug delivery 23 (3), 958-970, 2016
772016
Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil
P Sharma, S Ganta, WA Denny, S Garg
International journal of pharmaceutics 367 (1-2), 187-194, 2009
662009
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion
S Ganta, P Sharma, JW Paxton, BC Baguley, S Garg
Journal of drug targeting 18 (2), 125-133, 2010
552010
Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer
S Ganta, A Singh, NR Patel, J Cacaccio, YH Rawal, BJ Davis, MM Amiji, ...
Pharmaceutical research 31, 2490-2502, 2014
532014
EGFR targeted theranostic nanoemulsion for image-guided ovarian cancer therapy
S Ganta, A Singh, P Kulkarni, AW Keeler, A Piroyan, RR Sawant, ...
Pharmaceutical research 32, 2753-2763, 2015
442015
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers
NR Patel, A Piroyan, S Ganta, AB Morse, KM Candiloro, AL Solon, ...
Cancer biology & therapy 19 (7), 554-564, 2018
432018
Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian …
M Talekar, S Ganta, A Singh, M Amiji, J Kendall, WA Denny, S Garg
Pharmaceutical research 29, 2874-2886, 2012
412012
Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy
M Talekar, S Ganta, M Amiji, S Jamieson, J Kendall, WA Denny, S Garg
International journal of pharmaceutics 450 (1-2), 278-289, 2013
402013
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20